Dr. Hong and Dr. Qadan discuss how the Cancer Center has had to postpone some cancer surgeries due to the COVID-19 pandemic, how these patients are being managed and how the Cancer Center is prioritizing each and every patient going forward.
Motaz Qadan, MD, PhD
Motaz Qadan, MD, PhD
Gapontsev Family Endowed Chair in Surgical Oncology
Associate Professor of Surgery
Departments, Centers, & Programs:
Boston: Massachusetts General Hospital
Department of Surgery
55 Fruit Street
Boston, MA 02114-2696
- MD, University of Edinburgh
- PHD, University of Louisville
- Residency, Stanford University Hospital and Clinics
- Residency, Stanford University Medical Center
- Fellowship, Memorial Sloan Kettering Cancer Center
American Board Certifications
- Surgery, American Board of Surgery
- Complex General Surgical Oncology, American Board of Surgery
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
The Qadan laboratory focuses on the tumor microenvironment in pancreas cancer. Current scientific and translational efforts in his laboratory include the evaluation of the radiosensitizing effects of Losartan and introduction of Fingolimod (sphingosine-1-phosphate receptor 1 antagonist) for endothelial barrier disruption in orthotopic pancreatic tumor models.
Dr. Qadan is also interested in clinical outcomes health services research and leads a large group of researchers who focus on methods to collect, analyze, and improve outcomes related to cancer surgery at the institutional and national level. His projects have earned national recognition in the form of multiple prizes and awards over the last few months.
Dr. Qadan is an active clinical investigator in several high impact clinical trials. He is a principal investigator on a prehabilitation study entitled "Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program" where he enrolls patients in an exercise and nutrition program to improve their outcomes during treatment for pancreatic cancer.
Dr. Qadan is actively involved in many National societies and holds active leadership roles in several organizations. He has over 140 peer-reviewed scientific articles as well as several book chapters and scientific abstracts. Dr. Qadan is an active member of the Gastrointestinal Malignancies Program at the Dana-Farber/Harvard Cancer Center.
If you are interested in making a direct donation, please indicate the "Qadan Liver and Pancreas Research Fund". Donations are tax-deductible and handled by my colleague Ms. Meagan Coons of the MGH Development Office, 125 Nashua St, Suite 540, Boston, MA 02114. All donations are so greatly appreciated.
- Jun | 3 | 2020
The Department of Surgery invites Medical Students to join our core education and residency program faculty, as well as our chief of surgery, in a question-and-answer virtual forum open to the public, as a way to learn more about the Surgical Residency Program at Massachusetts General Hospital.